Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1996-10-28
|
pubmed:abstractText |
Catheter-directed thrombolytic therapy has become an accepted treatment for many vascular occlusions. However, the relative rates of lysis of the different methods of drug administration have not been quantified. We developed an in vitro model to simulate and quantify local lytic therapy of a thrombotic vascular occlusion and tested it by evaluating three catheter-directed lytic strategies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1076-6332
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8796652-Catheterization, Peripheral,
pubmed-meshheading:8796652-Humans,
pubmed-meshheading:8796652-Models, Structural,
pubmed-meshheading:8796652-Sodium Chloride,
pubmed-meshheading:8796652-Thrombolytic Therapy,
pubmed-meshheading:8796652-Thrombosis,
pubmed-meshheading:8796652-Urokinase-Type Plasminogen Activator
|
pubmed:year |
1996
|
pubmed:articleTitle |
In vitro model to evaluate the relative efficacy of catheter-directed thrombolytic strategies.
|
pubmed:affiliation |
Department of Radiology, New York Hospital-Cornell Medical Center, NY 10021, USA.
|
pubmed:publicationType |
Journal Article,
In Vitro
|